Navigation Links
Deadly Diarrhoea Vaccine – Trail Results Promising

Diarrhoea is a major cause of morbidity and mortality in India. An attempt to formulate// a vaccine against this deadly disease, which has claimed so many young lives, is worth the expense.

India is set to begin the phase II clinical trials of a new vaccine for a deadly form of diarrhoea that causes thousands of deaths annually in India. This move has been accelerated after phase I clinical trials showed up to 70 percent success among adults, children and infants. If the phase II trials are materialized, it is likely to yield more conclusive results towards complete protection from the disease.

The rotaviral diarrhoea contributes 40 percent of the dehydrating diarrhoea disease in infants and young children, causing 150,000 deaths annually in India, which proves that the investment is worthy.

The trial concentrated on the safety and immunogenicity of the two vaccines. The results revealed that the 116E based vaccine is safe and provides up to 70 percent protection with single dose in infants, which may increase to complete protection with two to three doses.

The phase II trial of the 116E vaccine is scheduled to be conducted in New Delhi.


Medindia on Diarrhoea: Replacement of fluids and electrolytes (salts and minerals) lost due to diarrhoea is the main aim. Self-treatment includes avoiding dehydration by drinking lots of electrolyte solutions that are available in all pharmacies and are dispensed without a prescription.

More on Medindia:


Page: 1

Related medicine news :

1. Smoking and Breast Cancer - A Deadly Combination
2. Latest Findings On The Deadly Disease - SARS
3. Sharp Increase Of The Deadly Diseases In Delhi
4. Imported Plants Could Deadly Harbor Mosquitoes, Says Report
5. Deadly Kiss - Peanut allergy kills a teenager
6. Deadly abortion pill takes two more lives
7. Severe Urinary Infection Could Lead To Deadly Blood Clots
8. Hush…..A Deadly Killer on the Prowl in Rural Andhra Pradesh
9. New Vaccine To Combat The Deadly Marburg Virus
10. Smoking and Obesity- A Deadly Combination
11. Tobacco Deadly In Any Form
Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at ... people age, more care is needed, especially with Alzheimer’s, dementia and other cognitive ... being overworked. The forgotten part of this equation: 80 percent of medical care ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... ... 2015 , ... "When I was traveling, I was very ... "Many people catch diseases simply from sitting on such dirty toilet seats. I ... germs." , He developed the patent-pending QUDRATECS to eliminate the need to sit ...
(Date:11/27/2015)... County, CA (PRWEB) , ... November 27, 2015 , ... ... season , The company is offering customers 10% off of their purchase of lice ... any treatment at full price. According to a company spokesperson. “Finding lice is a ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... au traitement photodynamique au Bremachlorin contre le cancer ... approche consistant à combiner l,immunothérapie au traitement photodynamique ... --> Une nouvelle approche consistant ... contre le cancer avancé.    ...
(Date:11/27/2015)... 2015 --> ... online. The potential to save costs, improve treatment quality ... from fully exploited as yet. Here, particular emphasis is ... via mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
Breaking Medicine Technology: